PUBLICATIONS · 38608694
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2024 May
- First author
- Campbell MT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2024 May;25(5):534-535. doi: 10.1016/S1470-2045(24)00151-7.
- note
- Source null
- related pmid
- 38608692
- relationship
- Comment in
Authors and identifiers
- name
- Campbell MT
- type
- Author
- name
- Balderrama-Brondani V
- type
- Author
- name
- Jimenez C
- type
- Author
- name
- Tamsen G
- type
- Author
- name
- Marcal LP
- type
- Author
- name
- Varghese J
- type
- Author
- name
- Shah AY
- type
- Author
- name
- Long JP
- type
- Author
- name
- Zhang M
- type
- Author
- name
- Ochieng J
- type
- Author
- name
- Haymaker C
- type
- Author
- name
- Habra MA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Campbell MT
- type
- Author
- name
- Balderrama-Brondani V
- type
- Author
- name
- Jimenez C
- type
- Author
- name
- Tamsen G
- type
- Author
- name
- Marcal LP
- type
- Author
- name
- Varghese J
- type
- Author
- name
- Shah AY
- type
- Author
- name
- Long JP
- type
- Author
- name
- Zhang M
- type
- Author
- name
- Ochieng J
- type
- Author
- name
- Haymaker C
- type
- Author
- name
- Habra MA
- type
- Author
- bibliography ids
- nci-bib-9bb8e406600576b352e7a5fb
- book metadata
- content sha256
- 1dceef038ef65d96ab490acd898bc005c78fec7df31b1e1a72e4b046ca1e6183
- document type
- citation
- dois
- 10.1016/S1470-2045(24)00095-0
- electronic publication date
- display
- 2024 Apr 9
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38608694
- immutable id
- pubmed:38608694@1dceef038ef65d96ab490acd898bc005c78fec7df31b1e1a72e4b046ca1e6183
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 5
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 649-657
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2024 May;25(5):534-535. doi: 10.1016/S1470-2045(24)00151-7.
- note
- Source null
- related pmid
- 38608692
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 38608694
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 24be900b48ef03e5d71e304378cd9844672a6b7cba71320bf2ae799e0dd8e9ec
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 May
- precision
- month
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Research Support, Non-U.S. Gov't
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Preserved source evidence · Not medical advice
Triangle